Patents by Inventor James E. Smous
James E. Smous has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9554735Abstract: A system for determining the concentration of an analyte in at least one body fluid in body tissue comprises an infrared light source, a body tissue interface, a detector, and a central processing unit. The body tissue interface is adapted to contact body tissue and to deliver light from the infrared light source to the contacted body tissue. The detector is adapted to receive spectral information corresponding to infrared light transmitted through the portion of body tissue being analyzed and to convert the received spectral information into an electrical signal indicative of the received spectral information. The central processing unit is adapted to compare the electrical signal to an algorithm built upon correlation with the analyte in body fluid, the algorithm adapted to convert the received spectral information into the concentration of the analyte in at least one body fluid.Type: GrantFiled: April 26, 2013Date of Patent: January 31, 2017Assignee: Ascensia Diabetes Care Holdings AGInventors: Mihailo V. Rebec, James E. Smous, Steven D. Brown, Hu-Wei Tan
-
Publication number: 20130261406Abstract: A system for determining the concentration of an analyte in at least one body fluid in body tissue comprises an infrared light source, a body tissue interface, a detector, and a central processing unit. The body tissue interface is adapted to contact body tissue and to deliver light from the infrared light source to the contacted body tissue. The detector is adapted to receive spectral information corresponding to infrared light transmitted through the portion of body tissue being analyzed and to convert the received spectral information into an electrical signal indicative of the received spectral information. The central processing unit is adapted to compare the electrical signal to an algorithm built upon correlation with the analyte in body fluid, the algorithm adapted to convert the received spectral information into the concentration of the analyte in at least one body fluid.Type: ApplicationFiled: April 26, 2013Publication date: October 3, 2013Applicant: Bayer HealthCare LLCInventors: Mihailo V. Rebec, James E. Smous, Steven D. Brown, Hu-Wei Tan
-
Patent number: 8452359Abstract: A system for determining the concentration of an analyte in at least one body fluid in body tissue comprises an infrared light source, a body tissue interface, a detector, and a central processing unit. The body tissue interface is adapted to contact body tissue and to deliver light from the infrared light source to the contacted body tissue. The detector is adapted to receive spectral information corresponding to infrared light transmitted through the portion of body tissue being analyzed and to convert the received spectral information into an electrical signal indicative of the received spectral information. The central processing unit is adapted to compare the electrical signal to an algorithm built upon correlation with the analyte in body fluid, the algorithm adapted to convert the received spectral information into the concentration of the analyte in at least one body fluid.Type: GrantFiled: October 10, 2007Date of Patent: May 28, 2013Assignee: Bayer HealthCare LLCInventors: Mihailo V. Rebec, James E. Smous, Steven D. Brown, Hu-Wei Tan
-
Patent number: 8160666Abstract: A system for determining the concentration of an analyte in at least one body fluid in body tissue comprises an infrared light source, a body tissue interface, a detector, and a central processing unit. The body tissue interface is adapted to contact body tissue and to deliver light from the infrared light source to the contacted body tissue. The detector is adapted to receive spectral information corresponding to infrared light transmitted through the portion of body tissue being analyzed and to convert the received spectral information into an electrical signal indicative of the received spectral information. The central processing unit is adapted to compare the electrical signal to an algorithm built upon correlation with the analyte in body fluid, the algorithm adapted to convert the received spectral information into the concentration of the analyte in at least one body fluid.Type: GrantFiled: October 12, 2007Date of Patent: April 17, 2012Assignee: Bayer Healthcare LLCInventors: Mihailo V. Rebec, James E. Smous, Steven D. Brown, Hu-Wei Tan
-
Patent number: 7944556Abstract: A spectral image is corrected for optical aberrations. Tissue is exposed to a high-intensity, narrow band of light. The narrow band of light is scattered by at least one analyte in the tissue. Raman signals are optically collected from the scattered light. The Raman signals are directed to a wavelength-separating device. The Raman signals are detected as a function of intensity and wavelength to create the spectral image. The spectral image is corrected for optical aberrations using a software algorithm to spatially reassign intensity. The software may be adapted to use a reference image to make dynamic corrections. Fluorescence signals may also be collected.Type: GrantFiled: March 11, 2010Date of Patent: May 17, 2011Assignee: Bayer HealthCare LLCInventors: James E. Smous, Mihailo V. Rebec, Michael P. Houlne
-
Patent number: 7896819Abstract: A method of obtaining a body fluid sample for determining the concentration of an analyte in the body fluid sample comprises applying pressure to the skin of the user. The skin is stretched so as to create a tear in the skin such that the applied pressure causes the body fluid to flow from the tear. The body fluid flowing from the tear is collected. Disclosed is also a pressure member for applying pressure to and stretching skin in preparation for forming a tear in the skin.Type: GrantFiled: October 20, 2005Date of Patent: March 1, 2011Inventors: Mihailo V. Rebec, James E. Smous, Bryan S. Melle, Pamela J. Burson
-
Publication number: 20100226549Abstract: A spectral image is corrected for optical aberrations. Tissue is exposed to a high-intensity, narrow band of light. The narrow band of light is scattered by at least one analyte in the tissue. Raman signals are optically collected from the scattered light. The Raman signals are directed to a wavelength-separating device. The Raman signals are detected as a function of intensity and wavelength to create the spectral image. The spectral image is corrected for optical aberrations using a software algorithm to spatially reassign intensity. The software may be adapted to use a reference image to make dynamic corrections. Fluorescence signals may also be collected.Type: ApplicationFiled: March 11, 2010Publication date: September 9, 2010Applicant: Bayer HealthCare, LLCInventors: JAMES E. SMOUS, Mihailo V. Rebec, Michael P. Houlne
-
Publication number: 20100113897Abstract: A continuous analyte monitoring assembly is adapted to assist in determining an analyte level of a fluid. The monitoring assembly includes a housing, electronics, an implantable sensor and a cannula. The housing has a bottom in which the bottom forms a recess. The electronics are located within the housing and assist in determining an analyte level of a fluid sample. The sensor moves from a retracted position to an inserted position using the recess. The cannula assists in placing the implantable sensor.Type: ApplicationFiled: March 14, 2008Publication date: May 6, 2010Applicant: Bayer Health Care LLCInventors: Allen J. Brenneman, James E. Smous
-
Patent number: 7705980Abstract: A spectral image is corrected for optical aberrations. Tissue is exposed to a high-intensity, narrow band of light. The narrow band of light is scattered by at least one analyte in the tissue. Raman signals are optically collected from the scattered light. The Raman signals are directed to a wavelength-separating device. The Raman signals are detected as a function of intensity and wavelength to create the spectral image. The spectral image is corrected for optical aberrations using a software algorithm to spatially reassign intensity. The software may be adapted to use a reference image to make dynamic corrections. Fluorescence signals may also be collected.Type: GrantFiled: August 21, 2007Date of Patent: April 27, 2010Assignee: Bayer Healthcare LLCInventors: James E. Smous, Mihailo V. Rebec, Michael P. Houlne
-
Publication number: 20080092638Abstract: A system for monitoring a concentration of an analyte in a fluid or tissue sample. The system comprises a sensor module adapted to be borne on a patient. The sensor module includes a power supply adapted to provide a transmission power, a first transceiver adapted to transmit analyte-concentration information, and a memory. The system further comprises a remote monitoring device adapted to wirelessly communicate with the sensor module. The remote monitoring device includes a second transceiver adapted to receive the analyte-concentration information transmitted by the sensor module and adapted to transmit a signal to the sensor module confirming that the analyte-concentration information was received. The information is stored in the memory until the signal is received by the sensor module.Type: ApplicationFiled: October 2, 2007Publication date: April 24, 2008Inventors: Allen J. Brenneman, Mihailo V. Rebec, James E. Smous
-
Patent number: 7299079Abstract: A system for determining the concentration of an analyte in at least one body fluid in body tissue, the system comprising an infrared light source, a body tissue interface, a detector, and a central processing unit. The body tissue interface is adapted to contact body tissue and to deliver light from the infrared light source to the contacted body tissue. The detector is adapted to receive spectral information corresponding to infrared light transmitted through the portion of body tissue being analyzed and to convert the received spectral information into an electrical signal indicative of the received spectral information. The central processing unit is adapted to compare the electrical signal to an algorithm built upon correlation with the analyte in body fluid, the algorithm adapted to convert the received spectral information into the concentration of the analyte in at least one body fluid.Type: GrantFiled: February 11, 2003Date of Patent: November 20, 2007Assignee: Bayer HealthCare LLCInventors: Mihailo V. Rebec, James E. Smous, Steven D. Brown, Hu-Wei Tan
-
Patent number: 7285425Abstract: A device for evaluating at least one analyte in a test sample. The device comprises a cassette having a hollow test chamber, a test strip disposed within the test chamber for receiving the test sample, and a temperature control member. The cassette has at least one aperture extending from an exterior of the cassette to the hollow test chamber. The test strip includes a reagent adapted to react with the at least one analyte to produce a reaction indicative of the presence of the analyte. The temperature control member is adapted to extend through the at least one aperture in the cassette and into the test chamber for controlling the temperature of the test chamber.Type: GrantFiled: May 14, 2002Date of Patent: October 23, 2007Assignee: Siemens Medical Solutions DiagnosticsInventors: Nazeer H. Shareef, James E. Smous, James P. Albarella
-
Publication number: 20040115832Abstract: A device for evaluating at least one analyte in a test sample. The device comprises a cassette having a hollow test chamber, a test strip disposed within the test chamber for receiving the test sample, and a temperature control member. The cassette has at least one aperture extending from an exterior of the cassette to the hollow test chamber. The test strip includes a reagent adapted to react with the at least one analyte to produce a reaction indicative of the presence of the analyte. The temperature control member is adapted to extend through the at least one aperture in the cassette and into the test chamber for controlling the temperature of the test chamber.Type: ApplicationFiled: October 22, 2003Publication date: June 17, 2004Inventors: Nazeer H. Shareef, James E. Smous, James P. Albarella
-
Publication number: 20040092804Abstract: A system for determining the concentration of an analyte in at least one body fluid in body tissue, the system comprising an infrared light source, a body tissue interface, a detector, and a central processing unit. The body tissue interface is adapted to contact body tissue and to deliver light from the infrared light source to the contacted body tissue. The detector is adapted to receive spectral information corresponding to infrared light transmitted through the portion of body tissue being analyzed and to convert the received spectral information into an electrical signal indicative of the received spectral information. The central processing unit is adapted to compare the electrical signal to an algorithm built upon correlation with the analyte in body fluid, the algorithm adapted to convert the received spectral information into the concentration of the analyte in at least one body fluid.Type: ApplicationFiled: February 11, 2003Publication date: May 13, 2004Applicant: Bayer Healthcare, LLCInventors: Mihailo V. Rebec, James E. Smous, Steven D. Brown, Hu-Wei Tan
-
Patent number: 5452390Abstract: A detachable fiber optic connector provides connection from an optical source or sink through a hermetic connection to a removable attached optical fiber. Ferrules and a split ring are used for alignment. A variety of alternative embodiments are illustrated for providing coupling force between the ferrules and retaining forces to prevent movement of the connection during movement of the fiber relative to the optical source or sink. These detachable fiber optic connectors provide great benefit when combined with hermetic packaging.Type: GrantFiled: April 22, 1994Date of Patent: September 19, 1995Assignee: CTS CorporationInventors: J. Scott Bechtel, Steven B. Creswick, James E. Smous
-
Patent number: 5450515Abstract: A detachable fiber optic connector provides connection from an optical source or sink through a hermetic connection to a removable attached optical fiber. Ferrules and a split ring are used for alignment. A variety of alternative embodiments are illustrated for providing coupling force between the ferrules and retaining forces to prevent movement of the connection during movement of the fiber relative to the optical source or sink. These detachable fiber optic connectors provide great benefit when combined with hermetic packaging.Type: GrantFiled: April 22, 1994Date of Patent: September 12, 1995Assignee: CTS CorporationInventors: J. Scott Bechtel, Steven B. Creswick, James E. Smous
-
Patent number: 5434941Abstract: A detachable fiber optic connector provides connection from an optical source or sink through a hermetic connection to a removable attached optical fiber. Ferrules and a split ring are used for alignment. A variety of alternative embodiments are illustrated for providing coupling force between the ferrules and retaining forces to prevent movement of the connection during movement of the fiber relative to the optical source or sink. These detachable fiber optic connectors provide great benefit when combined with hermetic packaging.Type: GrantFiled: April 22, 1994Date of Patent: July 18, 1995Assignee: CTS CorporationInventors: J. Scott Bechtel, Steven B. Creswick, James E. Smous
-
Patent number: 5432878Abstract: An optoelectronic subassembly is illustrated which ensures the alignment of multiple optoelectronic devices without special assembly process. The optoelectronic devices are mounted upon specially designed sub-carriers which may be used to test the devices prior to completing the subassembly. The subassembly improves yields of complex optoelectronic systems and lowers resultant production costs.Type: GrantFiled: March 3, 1994Date of Patent: July 11, 1995Assignee: CTS CorporationInventor: James E. Smous
-
Apparatus for nondestructively determining coating thickness on a metal object and associated method
Patent number: 5281819Abstract: Apparatus and an associated method for nondestructively determining the thickness of a coating on a metal surface, such as the interior of a can. An object securing device holds the object being inspected. The inspection device includes a probe. Positioning apparatus is employed to permit insertion of the probe into inspecting relationship which in the case of a can would involve partial insertion of the probe into the can. A first section is inspected and sequentially through relative rotational and/or translational movement of the object being inspected additional portions of the object such as can ends may be inspected. A light beam is caused to impinge upon the section of the object being inspected and returned fluorescent light received by a detector positioned within the probe cooperates with processing means to determine the coating thickness. The system permits accurate determinations of coating thickness even when the metal surface has irregularities.Type: GrantFiled: June 6, 1991Date of Patent: January 25, 1994Assignee: Aluminum Company of AmericaInventors: Richard G. Keffert, M. Jonell Kerkhoff, James E. Smous, Richard G. Keffert